C.G. Papaloisou and Merck Serono extend their co-operation
Date: 21 Dec 2009

C.G. Papaloisou and Merck Serono, the biopharmaceutical division of Merck KGaA, have agreed to extend their co-operation in Cyprus.

As from the 1st of January 2010, C.G. Papaloisou will be responsible for the distribution in Cyprus of important Merck Serono pharmaceutical products in the oncology, neurology, fertility and cardiometabolic therapeutic areas. For further details click here.

The co-operation between the two companies goes back to 1976, when C.G. Papaloisou undertook the distribution of pharmaceutical products by the French company Lipha SA, which was later acquired by Merck KGaA.